3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Conditions
Breast Neoplasms
1152
Prostatic Neoplasms
642
Neoplasms
581
Carcinoma, Non-Small-Cell Lung
488
Multiple Myeloma
483
Leukemia, Myeloid, Acute
462
Leukemia
418
Lung Neoplasms
399
Lymphoma
381
Leukemia, Lymphocytic, Chronic, B-Cell
332
Precursor Cell Lymphoblastic Leukemia-Lymphoma
327
Lymphoma, Non-Hodgkin
326
Colorectal Neoplasms
310
Pancreatic Neoplasms
306
Neoplasm Metastasis
302
Myelodysplastic Syndromes
301
Melanoma
286
Hodgkin Disease
253
Head and Neck Neoplasms
249
Brain Neoplasms
231
Lymphoma, Follicular
224
Ovarian Neoplasms
221
Recurrence
220
Glioblastoma
215
Lymphoma, Mantle-Cell
212
Lymphoma, Large B-Cell, Diffuse
209
Squamous Cell Carcinoma of Head and Neck
176
Colonic Neoplasms
162
Carcinoma, Renal Cell
158
Carcinoma, Hepatocellular
154
Interventions
Vitamin E
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Has results
×
Cerebrovascular Disorders
×
Clear all
NCT03721952
2025-02-07
FCS2
University of Washington
Phase NA
Completed
977 enrolled
38 charts
NCT00000479
2012-06-15
WHS
Brigham and Women's Hospital
Phase 3
Completed
39,876 enrolled
11 charts